Company: RGBP
Filing Date: 2025-12-05
Form Type: 253G1
Source: 0001493152-25-026350
Chunk: 19

Company: Regen BioPharma Inc
Filing Date: 2025-12-05
Form: 253G1
Chunk 19
---
 or fiduciary capacity; any broker or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934; any insurance   
 company registered under the Investment Company Act of 1940 or a business development company as defined in Section 2(a)(48) of that  
 Act; any Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the      
 Small Business Investment Act of 1958; any plan established and maintained by a state, its political subdivisions, or any agency      
 or instrumentality of a state or political subdivisions, for the benefit of its employees, if such plan has total assets in excess    
 of $5,000,000; any employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, if the investment 
 decision is made by a plan fiduciary, as defined in Section 3(21) of such Act, which is either a bank, savings and loan association,  
 insurance company, or registered investment advisor, or if the employee benefit plan has total assets in excess of $5,000,000, or,    
 if a self-directed plan, with investment decisions made solely by persons that are accredited investors;                              |

<div align='center'>14</div>

| ● | Any                                                                                                           
 private business development company as defined in Section 202(a)(22) of the Investment Advisers Act of 1940; |

| ● | Any                                                                                                                                
 organization described in Section 501(c)(3) of the Internal Revenue Code, or corporation, Massachusetts or similar business trust, 
 or partnership, not formed for the specific purpose of acquiring the shares offered, with total assets in excess of $5,000,000;    |

| ● | Any                                                                                                                               
 director, executive officer, or general partner of the issuer of the securities being offered or sold, or any director, executive 
 officer, or general partner of a general partner of that issuer;                                                                  |

| ● | Any                                                                                                                        
 natural person whose individual net worth, or joint net worth with that person’s spouse or spousal equivalent, at the time 
 of his purchase (excluding the value of the person’s primary residence) exceeds $1,000,000;                                |

| ● | Any                                                                                                                               
 natural person who had an individual income in excess of $200,000 in each of the two most recent years, or joint income with that 
 person’s spouse or spousal equivalent in excess of $300